Raras
Buscar doenças, sintomas, genes...
Síndrome de contratura congênita letal
ORPHA:294965DOENÇA RARA

Síndrome caracterizada por contraturas articulares congênitas não progressivas. As contraturas podem envolver os membros superiores ou inferiores e/ou a coluna vertebral, levando a vários graus de limitações de flexão ou extensão evidentes ao nascimento.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome caracterizada por contraturas articulares congênitas não progressivas. As contraturas podem envolver os membros superiores ou inferiores e/ou a coluna vertebral, levando a vários graus de limitações de flexão ou extensão evidentes ao nascimento.

Publicações científicas
46 artigos
Último publicado: 2026 Apr 16
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +10
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
19 sintomas
💪
Músculos
15 sintomas
😀
Face
13 sintomas
🧠
Neurológico
6 sintomas
❤️
Coração
5 sintomas
👁️
Olhos
3 sintomas

+ 43 sintomas em outras categorias

Características mais comuns

Dorso nasal convexo
Morfologia anormal do osso cortical
Orelhas com rotação posterior
Anel de constrição amniótica
Anormalidade do osso do quadril
Fraturas recorrentes
115sintomas
Sem dados (115)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 115 características clínicas mais associadas, ordenadas por frequência.

Dorso nasal convexoConvex nasal ridge
Morfologia anormal do osso corticalAbnormal cortical bone morphology
Orelhas com rotação posteriorPosteriorly rotated ears
Anel de constrição amnióticaAmniotic constriction ring
Anormalidade do osso do quadrilAbnormality of the hip bone

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico46PubMed
Últimos 10 anos31publicações
Pico20207 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

11 genes identificados com associação a esta condição.

DNM2Dynamin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the hydrolysis of GTP and utilizes this energy to mediate vesicle scission at plasma membrane during endocytosis and filament remodeling at many actin structures during organization of the actin cytoskeleton (PubMed:15731758, PubMed:19605363, PubMed:19623537, PubMed:33713620, PubMed:34744632). Plays an important role in vesicular trafficking processes, namely clathrin-mediated endocytosis (CME), exocytic and clathrin-coated vesicle from the trans-Golgi network, and PDGF stimulated macr

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasmic vesicle, clathrin-coated vesicleCell projection, uropodiumEndosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleRecycling endosomeCell projection, phagocytic cupCytoplasmic vesicle, phagosome membraneCell projection, podosomeCytoplasmCell junctionPostsynaptic densitySynapse, synaptosomeMidbodyMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (1)
NOSTRIN mediated eNOS trafficking
MECANISMO DE DOENÇA

Myopathy, centronuclear, 1

A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
107.7 TPM
Skin Sun Exposed Lower leg
97.2 TPM
Sangue
94.9 TPM
Intestino delgado
92.3 TPM
Baço
85.9 TPM
OUTRAS DOENÇAS (5)
fetal akinesia-cerebral and retinal hemorrhage syndromeautosomal dominant centronuclear myopathyCharcot-Marie-Tooth disease dominant intermediate Bcentronuclear myopathy
HGNC:2974UniProt:P50570
ERBB3Receptor tyrosine-protein kinase erbB-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). May also be activated by CSPG5 (PubMed:15358134). Involved in the regulation of myeloid cell differentiation (PubMed:27416908)

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (5)
Signaling by ERBB2Signaling by ERBB4Signaling by ERBB2 TMD/JMD mutantsSignaling by ERBB2 KD MutantsDownregulation of ERBB2:ERBB3 signaling
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 2

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS2 patients manifest craniofacial/ocular findings, lack of hydrops, multiple pterygia, and fractures, as well as a normal duration of pregnancy and a unique feature of a markedly distended urinary bladder (neurogenic bladder defect). The phenotype suggests a spinal cord neuropathic etiology.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
116.8 TPM
Skin Sun Exposed Lower leg
71.9 TPM
Skin Not Sun Exposed Suprapubic
66.7 TPM
Esôfago - Mucosa
62.6 TPM
Glândula salivar
60.2 TPM
OUTRAS DOENÇAS (4)
visceral neuropathy, familial, 1, autosomal recessivelethal congenital contracture syndrome 2Hirschsprung diseaseerythroleukemia, familial, susceptibility to
HGNC:3431UniProt:P21860
ZBTB42Zinc finger and BTB domain-containing protein 42Disease-causing germline mutation(s) inModerado
FUNÇÃO

Transcriptional repressor. Specifically binds DNA and probably acts by recruiting chromatin remodeling multiprotein complexes

LOCALIZAÇÃO

CytoplasmNucleusNucleus, nucleoplasm

MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 6

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS6 features include severe polyhydramnios and absent stomach, in addition to multiple contracture deformities.

EXPRESSÃO TECIDUAL(Ubíquo)
Próstata
11.8 TPM
Tireoide
10.9 TPM
Glândula salivar
9.9 TPM
Estômago
8.5 TPM
Pâncreas
8.1 TPM
OUTRAS DOENÇAS (1)
lethal congenital contracture syndrome 6
HGNC:HGNC:32550UniProt:B2RXF5
ADCY6Adenylate cyclase type 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the formation of the signaling molecule cAMP downstream of G protein-coupled receptors (PubMed:17110384, PubMed:17916776). Functions in signaling cascades downstream of beta-adrenergic receptors in the heart and in vascular smooth muscle cells (PubMed:17916776). Functions in signaling cascades downstream of the vasopressin receptor in the kidney and has a role in renal water reabsorption. Functions in signaling cascades downstream of PTH1R and plays a role in regulating renal phosphate

LOCALIZAÇÃO

Cell membraneCell projection, ciliumCell projection, stereocilium

VIAS BIOLÓGICAS (10)
ADORA2B mediated anti-inflammatory cytokines productionG alpha (i) signalling eventsG alpha (z) signalling eventsG alpha (s) signalling eventsGPER1 signaling
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 8

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS8 is an axoglial form of arthrogryposis multiplex congenita, characterized by congenital distal joint contractures, reduced fetal movements, and severe motor paralysis leading to death early in the neonatal period.

OUTRAS DOENÇAS (1)
lethal congenital contracture syndrome 8
HGNC:237UniProt:O43306
NEK9Serine/threonine-protein kinase Nek9Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pleiotropic regulator of mitotic progression, participating in the control of spindle dynamics and chromosome separation (PubMed:12101123, PubMed:12840024, PubMed:14660563, PubMed:19941817). Phosphorylates different histones, myelin basic protein, beta-casein, and BICD2 (PubMed:11864968). Phosphorylates histone H3 on serine and threonine residues and beta-casein on serine residues (PubMed:11864968). Important for G1/S transition and S phase progression (PubMed:12840024, PubMed:14660563, PubMed:1

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Activation of NIMA Kinases NEK9, NEK6, NEK7
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 10

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
75.5 TPM
Fallopian Tube
70.1 TPM
Útero
69.4 TPM
Cervix Endocervix
67.2 TPM
Cervix Ectocervix
66.8 TPM
OUTRAS DOENÇAS (3)
NEK9-related lethal skeletal dysplasiaarthrogryposis, Perthes disease, and upward gaze palsynevus comedonicus syndrome
HGNC:18591UniProt:Q8TD19
GLE1mRNA export factor GLE1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. May be involved in the terminal step of the mRNA transport through the nuclear pore complex (NPC)

LOCALIZAÇÃO

NucleusCytoplasmNucleus, nuclear pore complex

VIAS BIOLÓGICAS (1)
Transport of Mature mRNA derived from an Intron-Containing Transcript
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 1

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS1 patients manifest early fetal hydrops and akinesia, micrognathia, pulmonary hypoplasia, pterygia, and multiple joint contractures. It leads to prenatal death.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
66.4 TPM
Linfócitos
52.3 TPM
Cérebro - Hemisfério cerebelar
35.0 TPM
Fibroblastos
31.7 TPM
Cerebelo
30.4 TPM
OUTRAS DOENÇAS (3)
lethal congenital contracture syndrome 1lethal arthrogryposis-anterior horn cell disease syndromeamyotrophic lateral sclerosis
HGNC:4315UniProt:Q53GS7
MYBPC1Myosin-binding protein C, slow-typeDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. Slow skeletal protein that binds to both myosin and actin (PubMed:31025394, PubMed:31264822). In vitro, binds to native thin filaments and modifies the activity of actin-activated myosin ATPase. May modulate muscle contraction or may play a more structural role

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Arthrogryposis, distal, 1B

A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. Distal arthrogryposis type 1 is characterized largely by camptodactyly and clubfoot. Hypoplasia and/or absence of some interphalangeal creases is common. The shoulders and hips are less frequently affected.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
3635.5 TPM
Próstata
54.5 TPM
Substância negra
28.0 TPM
Hipotálamo
19.2 TPM
Brain Nucleus accumbens basal ganglia
16.2 TPM
OUTRAS DOENÇAS (6)
lethal congenital contracture syndrome 4myopathy, congenital, with tremorarthrogryposis, distal, type 1Bdigitotalar dysmorphism
HGNC:7549UniProt:Q00872
GLDNGliomedinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand for NRCAM and NFASC/neurofascin that plays a role in the formation and maintenance of the nodes of Ranvier on myelinated axons. Mediates interaction between Schwann cell microvilli and axons via its interactions with NRCAM and NFASC. Nodes of Ranvier contain clustered sodium channels that are crucial for the saltatory propagation of action potentials along myelinated axons. During development, nodes of Ranvier are formed by the fusion of two heminodes. Required for normal clustering of so

LOCALIZAÇÃO

Cell membraneCell projection, axonSecretedSecreted, extracellular space, extracellular matrix

MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 11

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
48.6 TPM
Brain Spinal cord cervical c-1
40.5 TPM
Artéria tibial
27.0 TPM
Substância negra
17.8 TPM
Aorta
17.2 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
lethal congenital contracture syndrome 11fetal akinesia deformation sequence 1
HGNC:29514UniProt:Q6ZMI3
CNTNAP1Contactin-associated protein 1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Required, with CNTNAP2, for radial and longitudinal organization of myelinated axons. Plays a role in the formation of functional distinct domains critical for saltatory conduction of nerve impulses in myelinated nerve fibers. Demarcates the paranodal region of the axo-glial junction. In association with contactin involved in the signaling between axons and myelinating glial cells

LOCALIZAÇÃO

MembraneCell junction, paranodal septate junction

VIAS BIOLÓGICAS (1)
Neurofascin interactions
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 7

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS7 is a severe axoglial disease characterized by congenital distal joint contractures, polyhydramnios, reduced fetal movements, and motor paralysis leading to death early in the neonatal period.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
neuropathy, congenital hypomyelinating, 3lethal congenital contracture syndrome 7
HGNC:8011UniProt:P78357
PIP5K1CPhosphatidylinositol 4-phosphate 5-kinase type-1 gammaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the phosphorylation of phosphatidylinositol 4-phosphate (PtdIns(4)P/PI4P) to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2/PIP2), a lipid second messenger that regulates several cellular processes such as signal transduction, vesicle trafficking, actin cytoskeleton dynamics, cell adhesion, and cell motility (PubMed:12422219, PubMed:22942276). PtdIns(4,5)P2 can directly act as a second messenger or can be utilized as a precursor to generate other second messengers: inositol

LOCALIZAÇÃO

Cell membraneEndomembrane systemCytoplasmCell junction, focal adhesionCell junction, adherens junctionCell projection, ruffle membraneCell projection, phagocytic cupCell projection, uropodiumNucleus

VIAS BIOLÓGICAS (5)
Synthesis of PIPs at the plasma membranePI5P, PP2A and IER3 Regulate PI3K/AKT SignalingRegulation of CDH1 posttranslational processing and trafficking to plasma membraneSEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesionClathrin-mediated endocytosis
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 3

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS3 patients present at birth with severe multiple joint contractures and severe muscle wasting and atrophy, mainly in the legs. Death occurs minutes to hours after birth due to respiratory insufficiency. The phenotype can be distinguished from that of LCCS1 by the absence of hydrops, fractures and multiple pterygia, and from LCCS2 by the absence of neurogenic bladder defect.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
184.9 TPM
Cérebro - Hemisfério cerebelar
169.8 TPM
Testículo
113.0 TPM
Cólon sigmoide
86.1 TPM
Esôfago - Muscular
80.9 TPM
OUTRAS DOENÇAS (1)
lethal congenital contracture syndrome 3
HGNC:8996UniProt:O60331
ADGRG6Adhesion G-protein coupled receptor G6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Adhesion G-protein coupled receptor (aGPCR) for steroid hormones, such as progesterone and 17alpha-hydroxyprogesterone (17OHP) (PubMed:35394864, PubMed:39884271). Involved in many biological processes, such as myelination, sprouting angiogenesis, placenta, ear and cartilage development (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cycla

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 9

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
lethal congenital contracture syndrome 9
HGNC:HGNC:13841UniProt:Q86SQ4

Variantes genéticas (ClinVar)

247 variantes patogênicas registradas no ClinVar.

🧬 DNM2: NM_001005361.3(DNM2):c.1232C>G (p.Ala411Gly) ()
🧬 DNM2: NM_001005361.3(DNM2):c.1961A>G (p.Glu654Gly) ()
🧬 DNM2: NM_001005361.3(DNM2):c.1894-2A>T ()
🧬 DNM2: NM_001005361.3(DNM2):c.1557+195C>T ()
🧬 DNM2: NM_001005361.3(DNM2):c.162-6T>G ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 219 variantes classificadas pelo ClinVar.

131
88
Patogênica (59.8%)
VUS (40.2%)
VARIANTES MAIS SIGNIFICATIVAS
DST: DST, ARG1269TER [Pathogenic]
DST: NM_001374736.1:c.905A>G transition in exon 8, resulting in a his302-to-arg (H302... [Pathogenic]
ADGRG6: NM_198569.3(ADGRG6):c.931C>T (p.Arg311Ter) [Likely pathogenic]
GLE1: NM_001003722.2(GLE1):c.553del (p.Gln185fs) [Likely pathogenic]
CNTNAP1: NM_003632.3(CNTNAP1):c.730C>T (p.Gln244Ter) [Likely pathogenic]

Vias biológicas (Reactome)

53 vias biológicas associadas aos genes desta condição.

Toll Like Receptor 4 (TLR4) Cascade Retrograde neurotrophin signalling Gap junction degradation Formation of annular gap junctions NOSTRIN mediated eNOS trafficking MHC class II antigen presentation Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Recycling pathway of L1 Clathrin-mediated endocytosis NGF-stimulated transcription Degradation of CDH1 Signaling by ERBB2 Signaling by ERBB4 SHC1 events in ERBB2 signaling PIP3 activates AKT signaling GRB7 events in ERBB2 signaling Downregulation of ERBB2:ERBB3 signaling PI3K events in ERBB2 signaling Constitutive Signaling by Aberrant PI3K in Cancer RAF/MAP kinase cascade ERBB2 Regulates Cell Motility PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling ERBB2 Activates PTK6 Signaling Downregulation of ERBB2 signaling Signaling by ERBB2 KD Mutants Signaling by ERBB2 TMD/JMD mutants Glucagon signaling in metabolic regulation PKA activation PKA activation in glucagon signalling Adenylate cyclase activating pathway Adenylate cyclase inhibitory pathway Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Adrenaline,noradrenaline inhibits insulin secretion G alpha (s) signalling events G alpha (i) signalling events G alpha (z) signalling events Vasopressin regulates renal water homeostasis via Aquaporins Hedgehog 'off' state GPER1 signaling ADORA2B mediated anti-inflammatory cytokines production FCGR3A-mediated IL10 synthesis High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Activation of NIMA Kinases NEK9, NEK6, NEK7 Nuclear Pore Complex (NPC) Disassembly EML4 and NUDC in mitotic spindle formation Transport of Mature mRNA derived from an Intron-Containing Transcript Striated Muscle Contraction Neurofascin interactions Synthesis of PIPs at the plasma membrane SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion Regulation of CDH1 posttranslational processing and trafficking to plasma membrane EGR2 and SOX10-mediated initiation of Schwann cell myelination

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de contratura congênita letal

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome de contratura congênita letal

Centros para Síndrome de contratura congênita letal

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
30 papers (10 anos)
#1

Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.

Brain : a journal of neurology2026 Feb 07

The dystonin gene (DST) encodes three major isoforms, DST-a, DST-b and DST-e. Biallelic pathogenic variants in DST have previously been associated with two allelic monogenic disorders: hereditary sensory and autonomic neuropathy type VI (caused by a loss of DST-a) and epidermolysis bullosa simplex 3 (caused by a loss of DST-e). We investigated patients diagnosed with congenital myopathy using exome or genome sequencing. In 19 affected individuals from 14 unrelated families, we identified nine different variants in biallelic state located in exons 40-41, specific to DST-b. Affected individuals presented with severe neonatal myopathy characterized by arthrogryposis, hypotonia and dilated cardiomyopathy. Postnatal CPAP ventilation was required in nine patients, and seven died within the first three years of life. Survivors showed an improvement of symptoms, with the oldest three patients, now over 25 years old, exhibiting normal cognition and being ambulatory. RNA analyses demonstrated that transcripts encoding DST-b are predominantly expressed in skeletal muscle, heart tissue and cultured fibroblasts, but not in brain, matching the phenotypic spectrum. Patient-derived fibroblasts exhibited reduced DST mRNA expression. Proteomic analysis confirmed a reduction of DST protein levels due to an absence of the DST-b isoform. Muscle biopsies from four patients aged 1 month to 3 years revealed mild, non-specific myopathic changes. Ultrastructural analysis in three individuals showed mild and focal myofibrillar disruption and non-specific undulating nuclear membranes, with these changes observed in two cases each. Additionally, we identified two homozygous variants affecting both DST-a and DST-b isoforms in four patients from two unrelated families; all presented with severe arthrogryposis and died intrauterine or shortly after birth. Genotype-phenotype correlation in these patients and previously published cases with respective variants resulted in the definition of a DST-associated lethal congenital contracture syndrome. Our findings demonstrate that biallelic variants exclusively affecting DST-b cause an autosomal recessive congenital myopathy. Variants that also impact DST-a besides DST-b result in a more severe, lethal congenital contracture syndrome. The location of the variant within DST allows for phenotype prediction. We propose redefining DST as a disease-associated gene linked to four distinct allelic disease phenotypes.

#2

Human CNTNAP1 Variants Associated With Severe Neurological Deficits: Additional Cases and Literature Review.

Muscle & nerve2026 Apr

CNTNAP1 encodes the Contactin-Associated Protein 1 (CNTNAP1), also known as Caspr1, which is a transmembrane protein critical for nervous system function. CNTNAP1 is localized to the paranodal regions of all myelinated axons, flanking either side of the node of Ranvier. It plays a vital role in axonal domain organization and is essential for the propagation of action potentials along nerve fibers. This specialized arrangement of axonal domains, which contain distinct molecular complexes, enables saltatory conduction and significantly increases the speed and efficiency of neuronal communication. To date, there are 47 children with biallelic CNTNAP1 variants who have been reported exhibiting a wide spectrum of phenotypes including congenital hypomyelinating neuropathy, hypotonia, and joint contractures among other clinical features. In this review, we compiled all previously published cases and detailed the specific genetic variants of every known individual, including clinical manifestations. Additionally, we present seven new cases of individuals identified through direct collaborations with clinicians and families, bringing the total to 54 individuals who harbor biallelic variants in CNTNAP1. This review and the additional case studies demonstrate that while children with CNTNAP1 mutations can present with a broad spectrum of symptoms, there is a recurrence of key clinical features across these cases. These key features commonly include respiratory distress, generalized hypotonia, hypomyelination, intellectual disabilities, and reduced life expectancy. These newly described cases provide valuable insights into the phenotypic diversity of CNTNAP1 variants, deepening our understanding of the clinical impact in patients with this rare genetic disorder.

#3

ADGRG6-related disorder: a novel mutation resulting in distal arthrogryposis and a patchy neuropathy.

Neuromuscular disorders : NMD2025 Aug

Arthrogryposis multiplex congenita (AMC) is associated with >150 genes, including ADGRG6, which codes for an adhesion G protein-coupled receptor. Biallelic loss of function variants in ADGRG6 have been linked to lethal congenital contracture syndrome. Here we present an atypical, milder phenotype associated with a novel ADGRG6 variant. A 22-year-old female, born from non-consanguineous parents, presented with non-progressive, distal arthrogryposis of her limbs since birth. Clinical evaluation showed distal contractures of all four limbs, absent right biceps resulting in elbow flexion weakness and patchily absent reflexes. Sensory examination was normal. Neurophysiology found patchy absence of multiple action potentials. Genetic testing revealed a homozygous deletion-insertion variant in ADGRG6's last exon, predicted to extend the protein. We present a unique phenotype of distal arthrogryposis with a patchy neuropathy in a patient with a novel ADGRG6 mutation. We hypothesize that this variant results in a milder phenotype than previously reported loss-of-function mutations.

#4

In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responses.

The FEBS journal2025 Dec

The mRNA export factor GLE1 protein plays critical yet enigmatic functions in RNA processing and has been linked with multiple developmental disorders, including lethal congenital contracture syndrome 1 (LCCS1). Using in vivo genetic engineering to study disturbed GLE1 functions under physiological conditions, we demonstrate that total inactivation of GLE1 results in disorganization of the blastocyst inner cell mass and early embryonic lethality due to defects in lineage specification. In contrast, the knock-in mice genocopying the LCCS1-associated GLE1FinMajor variant (Gle1PFQ/PFQ) survive the prenatal period but die suddenly at midadulthood. Gle1PFQ/PFQ mice present an irregular count and distribution of spinal motor neurons as well as impaired development of neural crest-derived tissues, as demonstrated by defects in the sympathetic innervation of heart ventricles, irregularities in the paravertebral sympathetic ganglia volume, and decreased adrenal chromaffin cell counts. Unlike previously reported for yeast and HeLa cells, analysis of the molecular consequences of the GLE1FinMajor variant identified normal poly(A) + RNA distribution in Gle1PFQ/PFQ cells; however, cells were impaired in RNA and protein synthesis and simultaneously showed severely disturbed formation of G3BP stress granule assembly factor 1 (G3BP1)-positive stress granules. Intriguingly, stressed Gle1PFQ/PFQ cells show microRNA profiles indicative of impaired transcription, protein metabolism, nervous system development, and axon guidance, further corroborating our functional findings. Our results show the necessity of functional GLE1 for life and indicate that LCCS1 etiology is a result of the pathogenic GLE1FinMajor variant impinging differentiation of neural crest derivatives and leading to complex multiorgan defects.

#5

The evolving genetic landscape of neuromuscular fetal akinesias.

Journal of neuromuscular diseases2025 Sep

Fetal akinesia is a broad term used to describe absent (or reduced, fetal hypokinesia) fetal movements, and it can be detected as early as the first trimester. Depending on the developmental age of onset, anything that interferes or limits the normal in utero movement results in a range of deformations affecting multiple organs and organ systems. Arthrogryposis, also termed arthrogryposis multiplex congenita (AMC), is a definitive terminology for multiple congenital contractures, with two major subgroups; amyoplasia and distal arthrogryposis (DA). The spectrum includes fetal akinesia deformation sequence (FADS), lethal congenital contracture syndrome (LCCS), and multiple pterygium syndrome (MPS). Variants in more than >400 genes are known to cause AMC, and it is increasingly recognized that variants in genes encoding critical components (including ventral horn cell, peripheral nerve, neuromuscular junction, skeletal muscle) of the extended motor unit underlie ∼40% of presentations. With unbiased screening approaches, including sequencing of comprehensive disease gene panels, exomes and genomes, novel genes and phenotypic expansions associated with known human disease genes have been uncovered in the setting of fetal akinesia. Autosomal-recessive titinopathy is the most frequent genetic cause of AMC. Accurate genetic diagnosis is critical to genetic counseling and informing family planning. Around 50% remain undiagnosed following comprehensive prenatal, diagnostic or research screening. Comprehensive phenotyping and periodic reanalysis with appropriate genomic tools are valuable strategies when faced with initial inconclusive results. There are likely many novel causative genes still to identify, which will inform our understanding of the molecular pathways underlying early human development and in utero movement.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC16 artigos no totalmostrando 31

2026

Human CNTNAP1 Variants Associated With Severe Neurological Deficits: Additional Cases and Literature Review.

Muscle & nerve
2025

ADGRG6-related disorder: a novel mutation resulting in distal arthrogryposis and a patchy neuropathy.

Neuromuscular disorders : NMD
2025

In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responses.

The FEBS journal
2026

Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.

Brain : a journal of neurology
2025

The evolving genetic landscape of neuromuscular fetal akinesias.

Journal of neuromuscular diseases
2025

Identification of a Founder GLDN Variant Associated With "Lethal" Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long-Term Survivors' Management.

American journal of medical genetics. Part A
2024

ERBB3 deficiency causes a multisystemic syndrome in human patient and zebrafish.

Clinical genetics
2023

Falling through the cracks: Failing to identify compromised Miranda abilities for defendants with limited cognitive capacities.

Behavioral sciences & the law
2022

Novel variants of NEK9 associated with neonatal arthrogryposis: Two case reports and a literature review.

Frontiers in genetics
2023

A novel biallelic variant c.2219T > A p.(Leu740*) in ADGRG6 as a cause of lethal congenital contracture syndrome 9.

Clinical genetics
2022

Lethal Congenital Contracture Syndrome 11: A Case Report and Literature Review.

Journal of clinical medicine
2022

Progressive Respiratory Insufficiency in a Teenager with Diaphragmatic Hypomotility Due to a Novel Combination of Gliomedin Gene Variants.

Children (Basel, Switzerland)
2022

Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.

European journal of translational myology
2022

[Analysis of CNTNAP1 gene variants in a Chinese pedigree affected with lethal congenital contracture syndrome type 7].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Models of Distal Arthrogryposis and Lethal Congenital Contracture Syndrome.

Genes
2020

A CNTNAP1 Missense Variant Is Associated with Canine Laryngeal Paralysis and Polyneuropathy.

Genes
2020

Biallelic variants in GLE1 with survival beyond neonatal period.

Clinical genetics
2020

The latest FADS: Functional analysis of GLDN patient variants and classification of GLDN-associated AMC as a type of viable fetal akinesia deformation sequence.

American journal of medical genetics. Part A
2020

Distal Arthrogryposis and Lethal Congenital Contracture Syndrome - An Overview.

Frontiers in physiology
2020

Extension of the phenotypic spectrum of GLE1-related disorders to a mild congenital form resembling congenital myopathy.

Molecular genetics & genomic medicine
2020

CNTNAP1 Mutations and Their Clinical Presentations: New Case Report and Systematic Review.

Case reports in medicine
2020

Expanding the clinical and molecular spectrum of lethal congenital contracture syndrome 8 associated with biallelic variants of ADCY6.

Clinical genetics
2019

GPR126: A novel candidate gene implicated in autosomal recessive intellectual disability.

American journal of medical genetics. Part A
2018

Absence of Axoglial Paranodal Junctions in a Child With CNTNAP1 Mutations, Hypomyelination, and Arthrogryposis.

Journal of child neurology
2018

A homozygous TTN gene variant associated with lethal congenital contracture syndrome.

American journal of medical genetics. Part A
2018

Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.

Neuropathology : official journal of the Japanese Society of Neuropathology
2017

Survival beyond the perinatal period expands the phenotypes caused by mutations in GLE1.

American journal of medical genetics. Part A
2017

Survival among children with "Lethal" congenital contracture syndrome 11 caused by novel mutations in the gliomedin gene (GLDN).

Human mutation
2018

A homozygous I684T in GLE1 as a novel cause of arthrogryposis and motor neuron loss.

Clinical genetics
2017

Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum.

Clinical genetics
2016

Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.

Neuroscience

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de contratura congênita letal.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de contratura congênita letal

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.
    Brain : a journal of neurology· 2026· PMID 40497796mais citado
  2. Human CNTNAP1 Variants Associated With Severe Neurological Deficits: Additional Cases and Literature Review.
    Muscle & nerve· 2026· PMID 41656591mais citado
  3. ADGRG6-related disorder: a novel mutation resulting in distal arthrogryposis and a patchy neuropathy.
    Neuromuscular disorders : NMD· 2025· PMID 40752141mais citado
  4. In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responses.
    The FEBS journal· 2025· PMID 40674274mais citado
  5. The evolving genetic landscape of neuromuscular fetal akinesias.
    Journal of neuromuscular diseases· 2025· PMID 40356365mais citado
  6. A case of CNTNAP1 gene-related abnormality and literature review.
    Technol Health Care· 2026· PMID 41989346recente
  7. Expanding the Prenatal Phenotype of Lethal Congenital Contracture Syndrome 11: Novel Homozygous GLDN Variant in a Family With Recurrent Affected Fetuses.
    Prenat Diagn· 2026· PMID 41903161recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:294965(Orphanet)
  2. MONDO:0017436(MONDO)
  3. GARD:12643(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q26492777(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de contratura congênita letal
Compêndio · Raras BR

Síndrome de contratura congênita letal

ORPHA:294965 · MONDO:0017436
MedGen
UMLS
C5848326
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades